Cargando…
Effective growth-suppressive activity of maternal embryonic leucine-zipper kinase (MELK) inhibitor against small cell lung cancer
Maternal embryonic leucine zipper kinase (MELK), that plays a critical role in maintenance of cancer stem cells (CSCs), is predominantly expressed in various types of human cancer including small cell lung cancer (SCLC). SCLC usually acquires resistance to anti-cancer drugs and portends dismal progn...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924666/ https://www.ncbi.nlm.nih.gov/pubmed/26871945 http://dx.doi.org/10.18632/oncotarget.7297 |
_version_ | 1782439897385140224 |
---|---|
author | Inoue, Hiroyuki Kato, Taigo Olugbile, Sope Tamura, Kenji Chung, Suyoun Miyamoto, Takashi Matsuo, Yo Salgia, Ravi Nakamura, Yusuke Park, Jae-Hyun |
author_facet | Inoue, Hiroyuki Kato, Taigo Olugbile, Sope Tamura, Kenji Chung, Suyoun Miyamoto, Takashi Matsuo, Yo Salgia, Ravi Nakamura, Yusuke Park, Jae-Hyun |
author_sort | Inoue, Hiroyuki |
collection | PubMed |
description | Maternal embryonic leucine zipper kinase (MELK), that plays a critical role in maintenance of cancer stem cells (CSCs), is predominantly expressed in various types of human cancer including small cell lung cancer (SCLC). SCLC usually acquires resistance to anti-cancer drugs and portends dismal prognosis. We have delineated roles of MELK in development/progression of SCLC and examined anti-tumor efficacy of OTS167, a highly potent MELK inhibitor, against SCLC. MELK expression was highly upregulated in both SCLC cell lines and primary tumors. siRNA-mediated MELK knockdown induced significant growth inhibition in SCLC cell lines. Concordantly, treatment with OTS167 exhibited strong cytotoxicity against eleven SCLC cell lines with IC(50) of < 10 nM. As similar to siRNA knockdown, OTS167 treatment induced cytokinetic defects with intercellular bridges, and in some cell lines we observed formation of neuronal protrusions accompanied with increase of a neuronal differentiation marker (CD56), indicating that the compound induced differentiation of cancer cells to neuron-like cells. Furthermore, the MELK inhibition decreased its downstream FOXM1 activity and Akt expression in SCLC cells, and led to apoptotic cell death. OTS167 appeared to be more effective to CSCs as measured by the sphere formation assay, thus MELK inhibition might become a promising treatment modality for SCLC. |
format | Online Article Text |
id | pubmed-4924666 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-49246662016-07-13 Effective growth-suppressive activity of maternal embryonic leucine-zipper kinase (MELK) inhibitor against small cell lung cancer Inoue, Hiroyuki Kato, Taigo Olugbile, Sope Tamura, Kenji Chung, Suyoun Miyamoto, Takashi Matsuo, Yo Salgia, Ravi Nakamura, Yusuke Park, Jae-Hyun Oncotarget Research Paper Maternal embryonic leucine zipper kinase (MELK), that plays a critical role in maintenance of cancer stem cells (CSCs), is predominantly expressed in various types of human cancer including small cell lung cancer (SCLC). SCLC usually acquires resistance to anti-cancer drugs and portends dismal prognosis. We have delineated roles of MELK in development/progression of SCLC and examined anti-tumor efficacy of OTS167, a highly potent MELK inhibitor, against SCLC. MELK expression was highly upregulated in both SCLC cell lines and primary tumors. siRNA-mediated MELK knockdown induced significant growth inhibition in SCLC cell lines. Concordantly, treatment with OTS167 exhibited strong cytotoxicity against eleven SCLC cell lines with IC(50) of < 10 nM. As similar to siRNA knockdown, OTS167 treatment induced cytokinetic defects with intercellular bridges, and in some cell lines we observed formation of neuronal protrusions accompanied with increase of a neuronal differentiation marker (CD56), indicating that the compound induced differentiation of cancer cells to neuron-like cells. Furthermore, the MELK inhibition decreased its downstream FOXM1 activity and Akt expression in SCLC cells, and led to apoptotic cell death. OTS167 appeared to be more effective to CSCs as measured by the sphere formation assay, thus MELK inhibition might become a promising treatment modality for SCLC. Impact Journals LLC 2016-02-10 /pmc/articles/PMC4924666/ /pubmed/26871945 http://dx.doi.org/10.18632/oncotarget.7297 Text en Copyright: © 2016 Inoue et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Inoue, Hiroyuki Kato, Taigo Olugbile, Sope Tamura, Kenji Chung, Suyoun Miyamoto, Takashi Matsuo, Yo Salgia, Ravi Nakamura, Yusuke Park, Jae-Hyun Effective growth-suppressive activity of maternal embryonic leucine-zipper kinase (MELK) inhibitor against small cell lung cancer |
title | Effective growth-suppressive activity of maternal embryonic leucine-zipper kinase (MELK) inhibitor against small cell lung cancer |
title_full | Effective growth-suppressive activity of maternal embryonic leucine-zipper kinase (MELK) inhibitor against small cell lung cancer |
title_fullStr | Effective growth-suppressive activity of maternal embryonic leucine-zipper kinase (MELK) inhibitor against small cell lung cancer |
title_full_unstemmed | Effective growth-suppressive activity of maternal embryonic leucine-zipper kinase (MELK) inhibitor against small cell lung cancer |
title_short | Effective growth-suppressive activity of maternal embryonic leucine-zipper kinase (MELK) inhibitor against small cell lung cancer |
title_sort | effective growth-suppressive activity of maternal embryonic leucine-zipper kinase (melk) inhibitor against small cell lung cancer |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924666/ https://www.ncbi.nlm.nih.gov/pubmed/26871945 http://dx.doi.org/10.18632/oncotarget.7297 |
work_keys_str_mv | AT inouehiroyuki effectivegrowthsuppressiveactivityofmaternalembryonicleucinezipperkinasemelkinhibitoragainstsmallcelllungcancer AT katotaigo effectivegrowthsuppressiveactivityofmaternalembryonicleucinezipperkinasemelkinhibitoragainstsmallcelllungcancer AT olugbilesope effectivegrowthsuppressiveactivityofmaternalembryonicleucinezipperkinasemelkinhibitoragainstsmallcelllungcancer AT tamurakenji effectivegrowthsuppressiveactivityofmaternalembryonicleucinezipperkinasemelkinhibitoragainstsmallcelllungcancer AT chungsuyoun effectivegrowthsuppressiveactivityofmaternalembryonicleucinezipperkinasemelkinhibitoragainstsmallcelllungcancer AT miyamototakashi effectivegrowthsuppressiveactivityofmaternalembryonicleucinezipperkinasemelkinhibitoragainstsmallcelllungcancer AT matsuoyo effectivegrowthsuppressiveactivityofmaternalembryonicleucinezipperkinasemelkinhibitoragainstsmallcelllungcancer AT salgiaravi effectivegrowthsuppressiveactivityofmaternalembryonicleucinezipperkinasemelkinhibitoragainstsmallcelllungcancer AT nakamurayusuke effectivegrowthsuppressiveactivityofmaternalembryonicleucinezipperkinasemelkinhibitoragainstsmallcelllungcancer AT parkjaehyun effectivegrowthsuppressiveactivityofmaternalembryonicleucinezipperkinasemelkinhibitoragainstsmallcelllungcancer |